- Report
- October 2025
- 99 Pages
Middle East
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 84 Pages
United States
From €4248EUR$4,850USD£3,687GBP
- Report
- June 2025
- 90 Pages
United States
From €4248EUR$4,850USD£3,687GBP
- Report
- May 2025
- 80 Pages
Africa, Middle East
From €2584EUR$2,950USD£2,242GBP
- Report
- May 2025
- 95 Pages
Asia Pacific
From €3022EUR$3,450USD£2,623GBP
- Report
- May 2025
- 96 Pages
Europe
From €3022EUR$3,450USD£2,623GBP
- Report
- May 2025
- 87 Pages
North America
From €2584EUR$2,950USD£2,242GBP
- Report
- May 2025
- 230 Pages
United States
From €3503EUR$4,000USD£3,041GBP
- Report
- July 2020
- 269 Pages
Global
From €3063EUR$3,497USD£2,658GBP
- Report
- June 2023
- 150 Pages
Global
From €3499EUR$3,995USD£3,037GBP
- Report
- May 2023
- 250 Pages
Global
From €3499EUR$3,995USD£3,037GBP
- Report
- August 2024
- 80 Pages
Global
From €1314EUR$1,500USD£1,140GBP
- Report
- June 2023
- 56 Pages
Global
€2146EUR$2,450USD£1,862GBP
- Report
- December 2022
- 56 Pages
China
€1397EUR$1,595USD£1,212GBP
- Report
- January 2025
- 343 Pages
Global
From €4203EUR$4,799USD£3,648GBP
- Report
- January 2025
- 252 Pages
China
From €4203EUR$4,799USD£3,648GBP
- Report
- February 2024
- 286 Pages
Global
From €4203EUR$4,799USD£3,648GBP
- Report
- March 2023
- 165 Pages
Global
From €4203EUR$4,799USD£3,648GBP
- Report
- January 2023
- 247 Pages
Global
From €4203EUR$4,799USD£3,648GBP
- Report
- January 2023
- 270 Pages
Global
From €4203EUR$4,799USD£3,648GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more